Originally published In Press as doi:10.1074/jbc.M101986200 on May 16, 2001
J. Biol. Chem., Vol. 276, Issue 29, 27731-27739, July 20, 2001
The Essential Smp3 Protein Is Required for Addition of the
Side-branching Fourth Mannose during Assembly of Yeast
Glycosylphosphatidylinositols*
Stephen J.
Grimme,
Barbara A.
Westfall,
Jill M.
Wiedman,
Christopher H.
Taron, and
Peter
Orlean
From the Department of Biochemistry, University of Illinois at
Urbana-Champaign, Urbana, Illinois 61801
Received for publication, March 5, 2001, and in revised form, May 15, 2001
 |
ABSTRACT |
The major glycosylphosphatidylinositols (GPIs)
transferred to protein in mammals and trypanosomes contain three
mannoses. In Saccharomyces cerevisiae, however, the GPI
transferred to protein bears a fourth,
1,2-linked Man on the
1,2-Man that receives the phosphoethanolamine (EthN-P) moiety
through which GPIs become linked to protein. We report that
temperature-sensitive smp3 mutants accumulate a GPI
containing three mannoses and that smp3 is epistatic to the
gpi11, gpi13, and gaa1 mutations,
which normally result in the accumulation of Man4-GPIs,
including the presumed substrate for the yeast GPI transamidase. The
Smp3 protein, which is encoded by an essential gene, is therefore
required for addition of the fourth Man to yeast GPI precursors. The
finding that smp3 prevents the formation of the
Man4-GPI that accumulates when addition of EthN-P to Man-3
is blocked in a gpi13 mutant suggests that the presence of
the fourth Man is important for transfer of EthN-P to Man-3 of yeast
GPIs. The Man3-GPI that accumulates in smp3 is
a mixture of two dominant isoforms, one bearing a single EthN-P side
branch on Man-1, the other with EthN-P on Man-2, and these isoforms can
be placed in separate arms of a branched GPI assembly pathway.
Smp3-related proteins are encoded in the genomes of
Schizosaccharomyces pombe, Candida albicans,
Drosophila melanogaster, and Homo sapiens and
form a subgroup of a family of proteins, the other groups of which are
defined by the Pig-B(Gpi10) protein, which adds the third GPI mannose,
and by the Alg9 and Alg12 proteins, which act in the dolichol pathway
for N-glycosylation. Because Man4-containing GPI precursors are normally formed in yeast and Plasmodium
falciparum, whereas addition of a fourth Man during assembly of
mammalian GPIs is rare and not required for GPI transfer to protein,
Smp3p-dependent addition of a fourth Man represents
a target for antifungal and antimalarial drugs.
 |
INTRODUCTION |
Glycosylphosphatidylinositols
(GPIs)1 with the conserved
core structure
H2N-CH2-CH2-PO4-6Man
1,2Man
1,6Man
1,4GlcN
1,6Ins
phospholipid are made by all eukaryotes. Many GPIs are transferred to
the COOH terminus of secretory glycoproteins and serve as membrane
anchors, but others remain protein-free (1-3). In Saccharomyces
cerevisiae, mannoproteins can be transferred from their GPI anchor
to cell wall
-glucan (4, 5). The formation of GPIs is essential for
growth of yeasts, Leishmania mexicana, and the bloodstream form of Trypanosoma brucei and for embryonic development in
mammals (6-10).
GPIs are preassembled on an inositol phospholipid in a stepwise
pathway, the enzymes of which are localized in membranes of the
endoplasmic reticulum (2, 3, 11, 12). During its assembly, the
glycan core of the GPI precursor can be decorated with side branches.
In yeast and mammals, the first and second mannoses can be modified
with phosphoethanolamine (EthN-P) (11-23), and late stage GPI
precursors made in wild type S. cerevisiae and
Plasmodium falciparum cells late-stage GPI precursors bear a
fourth,
1,2-linked Man on the third,
1,2-linked Man of the glycan
core (24-26). Yeast mutants deficient in EthN-P addition to Man-2 and
Man-3 and in GPI transfer to protein accumulate GPIs with four mannoses
(21, 22, 27, 28). In contrast, in mammalian cells, the largest glycan
headgroups characterized contain only three mannoses (13-18), although
it has been suggested that minor amounts of Man4 species
may be formed (13, 18, 29). Protein-bound GPIs in mammals usually
contain three mannoses, but a fourth,
1,2-linked Man has been
detected on the GPI anchor of the murine Thy-1 glycoprotein (30) and
human renal membrane dipeptidase (31).
We report that the S. cerevisiae Smp3 protein, a member of a
family of potential dolichyl phosphate (Dol-P) Man-utilizing mannosyltransferases, is a candidate for the enzyme that adds the
fourth Man during yeast GPI assembly. Temperature-sensitive smp3 mutations prevent the formation of
Man4-GPIs and result in the accumulation of
Man3-GPIs. Addition of the fourth mannose is therefore
required to generate the Man4-GPIs that are the most likely
substrates for the yeast GPI transamidase. Because the SMP3
gene is essential, and because addition of a fourth Man seems to be of
much greater relative importance in GPI assembly in yeast than it is in
mammalian cells, addition of the fourth Man represents a potential
target for antifungal drugs.
 |
EXPERIMENTAL PROCEDURES |
Materials--
[2-3H]myo-Inositol
(specific activity, 15-20 Ci/mmol) and
[1-3H]ethanolamine (specific activity, 10-30 Ci/mmol)
were obtained from American Radiolabeled Chemicals (St. Louis, MO).
Tran35S-label mixture (specific activity, 1 Ci/mmol)
and phosphatidylinositol-specific phospholipase C were from ICN
Biochemicals, and jack bean and Aspergillus satoi
-mannosidases from Oxford GlycoSciences (Oxford, United Kingdom).
Silica gel 60 HPTLC 5631/5 plates were supplied by Altech (Deerfield, IL).
Yeast Strains and Media--
The yeast strains used in this work
are listed in Table
I, and
the construction of those strains made specifically for this study is
detailed below. YPD and SD medium were prepared as described in Ref.
32, and YPGal medium had the same composition as YPD but contained 2%
(w/v) galactose instead of glucose. SGlyYE, SGlcYE, and SGalYE were as
described in Ref. 22, except that SGlcYE contained 2% (w/v)
glucose.
View this table:
[in this window]
[in a new window]
|
Table I
S. cerevisiae strains used in this study
The procedures used to construct new strains for this study and
references to previous descriptions of strains are given under
"Experimental Procedures."
|
|
The smp3 strain KH8 (33) was back-crossed twice to strain
YMW2 (34) to generate the smp3-1 and smp3-1D
strains. The smp3-2 and gaa1-2 strains were
isolated in a screen for mutants that require the GPI1 gene
for growth,2 conducted using
the vectors and strains described in Ref. 34. Both primary isolates
were back-crossed twice to strain YMW1. The cross of smp3-1
to
gpi1-8H yielded viable
smp3-1/
gpi1 haploids. An
smp3/gpi11 strain was generated by crossing
smp3-1 with strain
gpi11-pPIG-F (22).
smp3/gpi13 "double mutants" were created by crossing
haploid smp3-1 or smp3-2 strains with a haploid
gpi13::KANR-pGAL-GPI13
strain (22) and allowing the resulting diploids to sporulate. Asci were
dissected, and ascospores were allowed to germinate on YP-galactose
medium supplemented with 0.25 M KCl. The genotypes of
segregants from tetratype tetrads were determined from the segregation
of selectable markers and temperature sensitivity among these strains
and confirmed by the thin-layer chromatographic profiles of their
[3H]inositol-labeled lipids. The
smp3/
gpi13-pGAL-GPI13 double
mutants grew more slowly at 25 °C on solid YPGal medium than the
single mutants unless osmotic support was provided.
smp3/gaa1 double mutants were generated in a genetic cross
of the smp3-1 and gaa1-2 strains. The
smp3/gaa1 segregants from tetratype tetrads were
distinguishable from the smp3-1 and gaa1-2 single
mutation because, unlike the single mutants, they failed to grow at
37 °C on solid YPD medium supplemented with 0.25 M KCl.
The presence of both the smp3 and gaa1 mutations
in these strains was confirmed by introducing the SMP3 gene
on a plasmid; at nonpermissive temperature, the double mutants showed
the profile of [3H]inositol-labeled lipids characteristic
of gaa1, not smp3 (see Fig. 2A).
smp3-1 was crossed into an ethanolamine-auxotrophic
psd1/
psd2 strain
background (RYY51) (35) to generate a strain capable of enhanced
incorporation of exogenous ethanolamine into lipid. Media for growth of
the
smp3-1/
psd1/
psd2
strain were supplemented with 2 mM ethanolamine and 2 mM choline.
A heterozygous smp3::KanR/SMP3
disruptant, generated by the Saccharomyces Deletion Project,
was obtained from Research Genetics (Huntsville, AL). Plasmid
pSMP3-426, in which SMP3 is expressed behind its
native promoter, was made by using polymerase chain reaction to amplify
a genomic DNA fragment containing SMP3 and 401 nucleotides
immediately upstream of the start codon and 336 nucleotides immediately
downstream of the SMP3 coding region, after which the DNA
fragment was cloned into the 2µ plasmid pRS426 (36). Plasmid
pGAL-SMP3, in which expression of SMP3 is under the control of the glucose-repressible GAL10 promoter, was made by
using polymerase chain reaction to amplify the SMP3 coding region from genomic DNA and cloning the resulting DNA fragment between the GAL10 promoter and the GAL7 termination region of plasmid
pMW20 (34), yielding plasmid pGAL-SMP3. Haploid
smp3::KanR strains complemented by
pSMP3-426 or pGAL-SMP3 were generated by
introducing these plasmids into the
smp3::KanR/SMP3 strain,
allowing the diploids to sporulate, and recovering kanamycin-resistant
smp3::KanR-pSMP3-426 or
pGAL-SMP3 strains from the tetrads that yielded four viable
segregants. Both plasmids therefore expressed functional Smp3p.
A gpi10::LEU2/GPI10 diploid was
generated by replacing 95% of the GPI10 coding region with
the selectable marker LEU2 using the strategy previously
used to disrupt the GPI11 gene (22). Plasmid
pGPI10-426, in which GPI10 is expressed behind
its native promoter, was made by using polymerase chain reaction to
amplify a genomic DNA fragment containing GPI10, 465 nucleotides immediately upstream of the start codon, and 337 nucleotides immediately downstream of the GPI10 coding
region, after which the DNA fragment was cloned into the 2µ
plasmid pRS426. This plasmid was introduced into
gpi10::LEU2/GPI10 diploids, which were
then allowed to sporulate. The resulting asci were dissected, and
gpi10::LEU2-pGPI10-426 segregants were recovered from tetrads that gave four viable segregants, indicating that pGPI10-426 expressed functional Gpi10p.
Radiolabeling of Lipids--
For [3H]inositol
labeling, logarithmically growing cells were resuspended at 10 A600 units/ml in inositol-free synthetic
medium, shifted as appropriate to nonpermissive temperature for 20 min, and then labeled with 15 µCi of [3H]inositol for 90 min. For [3H]inositol labeling of GPIs in the
smp3::KanR-pGAL-SMP3 strain,
cultures were grown in SDGlyYE medium, cells were then resuspended in
SDGlcYE medium for 16 h to repress SMP3 expression, and
cultures were then pulse-labeled with [3H]inositol for
2 h as detailed in Ref. 22. In the case of the smp3/
gpi13-pGAL-SMP3 strain,
GPI13 expression was likewise repressed by incubation in
SDGlcYE medium at 25 °C, after which portions of the culture were
either maintained at 25 °C or shifted to 37 °C for 20 min before
pulse labeling with [3H]inositol (22). For
[3H]ethanolamine labeling, strains were grown in SD
medium supplemented with choline and ethanolamine and then washed and
radiolabeled with 50 µCi of ethanolamine in SD medium lacking
ethanolamine. Radiolabeled lipids were extracted and separated by TLC
using chloroform/methanol/water (10:10:2.5 by volume) as solvent (22).
Characterization of Glycan
Headgroups--
[3H]inositol-labeled lipids from 500 A600 units of smp3-1 cells labeled at
25 °C were purified by two rounds of preparative TLC. Size analyses
of the neutral glycan headgroup of the de-acylated lipid, jack bean, or
A. satoi
1,2-mannosidase sensitivity determinations and
positioning of EthN-P side-branches were carried out following protocols described in Refs. 22 and 37. A Man4-GlcNAc
standard was obtained from the Man4-GPI that accumulates in
the gpi7-deleted strain (21, 22), and a
Man3-GlcNAc standard was prepared isolated after jack bean
-mannosidase treatment followed by dephosphorylation of the
deacylated gpi7 lipid.
35S Labeling and Immunoprecipitation of
Gas1p--
Pulse labeling with Tran35S-label mixture,
chasing with unlabeled methionine and cysteine, and immunoprecipitation
of Gas1p were carried out as described previously (38).
Amino Acid Sequence Analyses--
The amino acid sequences of
other eukaryotic proteins resembling S. cerevisiae Smp3p
(NP_014792), Gpi10p (NP_011373), Alg9p (NP_014180), and Alg12p
(NP_014427) were identified in Psi-BLAST, BLASTp, or tBLASTn searches
(39, 40) of the NCBI, Sanger Center, and Stanford DNA Sequencing and
Technology Center data bases. Each new amino acid sequence was used as
probe in a Psi-BLAST search of all S. cerevisiae proteins,
and the new protein was then provisionally designated the counterpart
of the S. cerevisiae protein with which it gave the
alignment with the lowest E value and to which it showed the highest
level of amino acid identity and similarity. The
GenBankTM accession numbers of the
Schizosaccharomyces pombe Smp3p, Gpi10p, Alg9p, and Alg12p
counterparts are Q09837, T41079, T50116, and T39659, respectively. The
accession numbers of the Drosophila Smp3p, Gpi10p, Alg9p,
and Alg12p counterparts are AAF47201, AAF47795, AAF56419, and AAF54441,
respectively. The accession numbers of the human Smp3p, Gpi10p, Alg9p,
and Alg12p counterparts are BAB14263, NP_004846 (Pig-B), BAB15154, and
AAH01729 respectively. The Candida albicans proteins are
encoded by the following contigs of genomic DNA from C. albicans strain SC5314, sequenced by the Stanford DNA Sequencing
and Technology Center: CaSmp3p by nucleotides 5967-7460 of
contig6-2467, CaGpi10p by nucleotides 14358-15803 of
contig6-2493, CaAlg9p by nucleotides 40345-42024 of contig6-2488,
and CaAlg12p by nucleotides 38706-40457 of contig6-2478. Sequence
data for C. albicans were obtained from the Stanford DNA
Sequencing and Technology Center web site. Sequencing of
C. albicans was accomplished with the support of the
National Institute of Dental and Craniofacial Research and the
Burroughs Wellcome Fund. Amino acid sequences were aligned using the
CLUSTAL W program (41), and an unrooted phylogenetic tree was generated from that alignment using the DRAWTREE option of the PHYLIP program (42), including positions with gaps and not correcting for multiple substitutions or using branch lengths.
 |
RESULTS |
Identification of Smp3p as a Candidate GPI
Mannosyltransferase--
Because the fourth Man is added to the yeast
GPI precursor in the endoplasmic reticulum (24), and because the three
core mannoses added to the GPI precursor in the endoplasmic reticulum are donated by Dol-P-Man (2, 3, 11, 43), the fourth Man on yeast GPIs
might also be expected to originate from Dol-P-Man. Two lines of
evidence suggested that the Smp3 protein might be a Dol-P-Man-utilizing
mannosyltransferase involved in GPI assembly. First, the S. cerevisiae genome encodes several proteins similar to Pig-Bp (19,
20, 43, 44), which is required for addition of the
1,2-linked Man to
mammalian GPIs (43). Of these, Gpi10p is the functional homolog of
Pig-Bp (19, 20), and Alg9p and Alg12p are nonessential proteins
involved in mannosyl transfer to the dolichol-linked precursor in
N-glycosylation (45). The SMP3 gene encodes a
fourth related protein. The temperature-sensitive smp3-1
mutant had previously been isolated in a screen for yeast mutants that
stably maintained a heterologous plasmid (33), and its availability
allowed us to test it for a defect in GPI anchoring. Genetic evidence
implicating Smp3p in GPI anchoring came from the fact that we isolated
an allele of SMP3 in a screen for mutants that require the
GPI1 gene for growth.2 Gpi1p, which is necessary
for growth at 37 °C but not 25 °C, is a subunit of the protein
complex that catalyzes the first step in GPI assembly, the formation of
GlcNAc-PI (38, 46). The premise behind our synthetic lethality screen
was that an additional mutation affecting GPI assembly or transfer to
protein might be lethal when combined with the
gpi1 mutation. One temperature-sensitive strain isolated in this way was complemented by a centromeric plasmid
(47) containing SMP3 that we recovered from a genomic yeast
DNA library. We confirmed by integrative transformation that the cloned
SMP3 gene was closely linked to the locus conferring temperature sensitivity, and we refer to this mutation as
smp3-2.
The temperature-sensitive growth phenotype of both the
smp3-1 and smp3-2 alleles was osmotically
remediable; inclusion of either 0.25 M KCl or 1 M sorbitol in solid medium restored the ability of these
strains to grow at 37 °C. Although SMP3 was shown to be
an essential gene (33), we tested whether haploid smp3 disruptants might be capable of vegetative growth if given osmotic support. Heterozygous
smp3::KanR/SMP3 diploids were
allowed to sporulate, and the resulting asci were dissected onto solid
YPD medium or onto YPD medium supplemented with 0.6 M KCl
or 1.0 M sorbitol. When ascospores were dissected onto YPD
medium, only the two kanamycin-sensitive, wild type segregants gave
rise to colonies, whereas the smp3::KanR
segregants either failed to germinate or failed to divide. When dissected onto osmotically supported YPD medium, the
smp3::KanR segregants completed 4-8
rounds of cell division but then ceased further growth. We conclude
that Smp3p is essential for vegetative growth.
smp3 Mutants Accumulate a Candidate GPI Precursor--
To
establish whether smp3 mutants are defective in GPI
synthesis, we tested whether they accumulate an intermediate in the GPI
synthetic pathway. Accumulation of a precursor provides a more
sensitive indication of a GPI assembly defect in late-stage yeast GPI
anchoring mutants than testing for defects in GPI transfer to protein
can. For example, the gpi10-1 mutant accumulates a Man2-containing GPI precursor but incorporates normal
amounts of [3H]inositol into proteins (19).
The smp3-1 and smp3-2 mutants, a wild type
strain, and smp3 mutants harboring a
centromeric library plasmid containing the SMP3 gene were
pulse-labeled with [3H]inositol at 25 and 37 °C, after
which labeled lipids were extracted from the cells and separated by
TLC. Both strains accumulated a major
[3H]inositol-labeled lipid (3-1), as well as a minor,
less polar species (3-2), suggesting that they have a defect in GPI
synthesis (Fig. 1A, lanes 3, 4, 7, and 8). Accumulation of lipid 3-1 was highest at
25 °C in the smp3-1 strain, whereas smp3-2
accumulated somewhat more at 37 °C. Lipid accumulation by both
smp3 strains was abolished when the SMP3 gene was
introduced into these strains on a centromeric plasmid (Fig. 1A,
lanes 5, 6, 9, and 10), strongly suggesting that their
GPI synthetic defect is due to a mutation in the SMP3
gene.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 1.
smp3 mutants accumulate a
candidate GPI precursor. A, accumulation of
[3H]inositol-labeled lipids and correction of this
phenotype by SMP3. Cells were labeled with
[3H]inositol at 25 or 37 °C, and radiolabeled lipids
were extracted, separated by TLC, and detected by fluorography.
Lanes 1 and 2, lipids from wild type cells;
lane pairs 3-4 and 7-8, lipids from
smp3-1 and smp3-2 cells, respectively; lane
pairs 5-6 and 9-10, lipids from smp3-1 and
smp3-2 cells harboring a centromeric plasmid expressing
SMP3 (pSMP3) behind its native promoter,
respectively. Odd-numbered lanes contain lipids labeled at
25 °C, and even-numbered lanes contain lipids
radiolabeled at 37 °C. B, depletion of Smp3p leads to
accumulation of lipid 3-1. The
smp3-pGAL-SMP3 strain was shifted
to SGlcYE medium to repress SMP3 expression as described
under Experimental Procedures, after which cultures were labeled with
[3H]inositol. A control culture incubated in SGalYE was
incubated and radiolabeled in parallel. Radiolabeled lipids were
extracted, separated by TLC, and detected by fluorography. Lane
1, culture shifted to glucose; lane 2 culture shifted
to galactose. C, mild base sensitivity and
phosphatidylinositol-specific phospholipase C resistance of lipid 3-1. Samples of lipids from smp3-1 cells labeled with
[3H]inositol at 25 °C were submitted to mild base
hydrolysis in methanolic NH3 (lane 2),
mock-treated with aqueous methanol (lane 1), incubated with
phosphatidylinositol-specific phospholipase C (lane 4), or
mock-treated (lane 3). Remaining lipids were extracted and
separated by TLC. D, radiolabeling of lipid 3-1 with
[3H]ethanolamine. The
psd1/ psd2
(WT) (lane 1) and
smp3-1/ psd1/ psd2
(s3) (lane 2) strains were radiolabeled with
[3H]ethanolamine, and the
smp3-1/ psd1/ psd2
strain was labeled in parallel with [3H]inositol
(s3) (lane 3). Radiolabeled lipids were separated
on the same TLC plate. o- indicates the origin of the
chromatogram.
|
|
To show that the lipid accumulation phenotype of the
temperature-sensitive smp3 mutants can be mimicked by depleting Smp3p in an smp3-disrupted strain, we isolated a haploid
smp3::KanR strain that was complemented by
a plasmid-borne copy of SMP3 under the control of the
glucose-repressible GAL10 promoter. A culture of
smp3::KanR-pGAL-SMP3 cells was
incubated in repressing medium for 16-48 h to allow them to become
depleted of Smp3p, after which they were pulse-labeled with
[3H]inositol. The glucose-repressed cells accumulated a
lipid with the same chromatographic mobility as lipid 3-1 accumulated
(Fig. 1B, lanes 1 and 2), indicating that lipid
3-1 indeed accumulates as a consequence of the loss of Smp3p function.
Lipid 3-2 was not unambiguously resolved in this experiment. Further
lipid labeling experiments were done with temperature-sensitive
smp3 strains.
Lipid 3-1 is sensitive to mild base hydrolysis but resistant to
hydrolysis by phosphatidylinositol-specific phospholipase C (Fig.
1C). The former property indicates the lipid has
ester-linked fatty acyl chains, and the latter is consistent with the
presence of an acyl chain esterified to the inositol; both are features of late-stage yeast GPI precursors (19, 20, 22-24). Lipid 3-1 could
also be radiolabeled with [3H]ethanolamine, consistent
with it being a GPI with one or more EthN-P moieties (Fig. 1D,
lane 2).
Epistasis Relationships of smp3--
To obtain genetic evidence
that lipid 3-1 is made in the GPI assembly pathway, we tested whether
its formation is abolished in a mutant defective in the first step in
GPI synthesis, and whether, in turn, smp3 blocks the
formation of late-stage and "complete" GPI precursors. Double
mutants were constructed between smp3 and (i)
gpi1, which blocks GlcNAc-PI synthesis, the
first step in GPI assembly (38); (ii) gpi11 (22), which is
defective in the yeast counterpart of human Pig-Fp (48) and accumulates two Man4-GPIs; (iii)
gpi13-pGAL-GPI13, in which
depletion of Gpi13p blocks addition of phosphoethanolamine to Man-3 and
leads to accumulation of a Man4-GPI bearing EthN-P on its
first Man (22); and (iv) gaa1, which is blocked in GPI
transfer to protein and accumulates the complete GPI precursor
CP2 (28).
The smp3-1/
gpi1 mutant did not
accumulate lipid 3-1 at either 25 or 37 °C (Fig.
2A, lanes 1-4), indicating
that 3-1 accumulation is dependent on formation of GlcNAc-PI and
placing the smp3 block downstream of
gpi1 in the GPI assembly pathway.
smp3, however, is epistatic to gpi11,
gaa1, and gpi13. In the
smp3-1/gpi11 strain, formation of
Man4-GPIs 11-1 (which bears two EthN-Ps, one of which is on
Man-3) and 11-2 (which bears a single EthN-P on Man-2; Fig. 2A,
lane 5) was almost completely prevented (Fig. 2A, lanes
6 and 7). In the smp3-1/gaa1
double mutant, accumulation of the complete precursor CP2, a
Man4-GPI with three EthN-Ps (19) (Fig. 2A, lane
8), was essentially abolished (Fig. 2A, lanes 9 and
10). We noted that the smp3/gaa1 double mutant
had a more severe growth defect than strains harboring the
smp3-1 or gaa1-2 mutations alone, because, in
contrast to the single mutants, the smp3/gaa1 strain did not
grow at 37 °C on solid YPD medium supplemented with 0.25 M KCl. Strikingly, the smp3-1 and
smp3-2 mutations inhibited the formation of the
Man-Man-Man-(EthN-P)Man-GPI (lipid 13-1) that accumulates in
Gpi13p-depleted strains (22) and did so in a temperature-sensitive
manner. After shifting the double mutants to 37 °C, formation of
lipid 13-1 was reduced in the
smp3-1/
gpi13-pGAL-GPI13 strain and
abolished in
smp3-2/
gpi13-pGAL-GPI13 (Fig.
2B, lanes 2, 3, 5, and 6), and lipid 3-1 accumulated as it does in smp3 single mutants. The
smp3 mutation therefore blocks the formation of the
Man4-GPIs that accumulate in strains defective in each of
three essential proteins that act late in the GPI anchoring pathway.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
Epistasis relationships of
smp3. A, the smp3-1,
gpi1, gpi11, and gaa1
mutants (lanes 1, 2, 5, and 8, respectively) and
smp3-1/ gpi1 (lanes 3 and
4), smp3-1/gpi11 (lanes 6 and 7), and smp3-1/gaa1 (lanes
9 and 10) double mutants were labeled with
[3H]inositol at 25 or 37 °C after a 20-min shift of
the culture to 37 °C, and radiolabeled lipids were extracted,
separated by TLC and detected by fluorography. Positions of lipids 3-1, 11-1, 11-2, and CP2 are indicated, and their structures are described
in the text. B,
smp3/ gpi13-pGAL-GPI13 strains were
incubated for 16 h at 25 °C in SGlcYE medium, and each culture
then divided into two portions, one of which was maintained at
25 °C, whereas the other was shifted to 37 °C for 20 min before
pulse labeling with [3H]inositol. Radiolabeled lipids
were then extracted and separated by TLC. Lanes 2 and
3, [3H]inositol-labeled lipids that accumulate
in the smp3-1/ gpi13-pGAL-GPI13
strain at 25 and 37 °C, respectively. Lanes 5 and
6, lipids radiolabeled in the
smp3-2/ gpi13-pGAL-GPI13 strain at
25 and 37 °C, respectively. Lipids radiolabeled in the
gpi13-pGAL-GPI13 strain after shift
to glucose-containing medium are displayed in lane 1, and
lipids labeled in the gaa1 and smp3-2 mutants at
37 °C are separated in lanes 4 and 7, respectively. The asterisk indicates the position of a
trace, aberrant lipid in lanes 5 and 6.
|
|
smp3 Is Blocked in Addition of a Fourth Man to GPI
Precursors--
The finding that smp3 blocks the
accumulation of Man4-GPIs is consistent with the notion
that the mutation prevents the addition of the fourth,
-1,2-linked
mannose to GPIs and led to the prediction that lipid 3-1 is a
Man3-GPI. We tested this by determining the structure of
the glycan headgroup of lipid 3-1. [3H]Inositol-labeled
3-1 was isolated by preparative TLC, and its neutral glycan headgroup
was obtained following deacylation, HF-dephosphorylation, and
re-N-acetylation. Portions of this material were submitted to size analysis by HPTLC without, or after, digestion with
-mannosidases. The full-size glycan from lipid 3-1 has a mobility
corresponding to that of Man3-GlcNAc-Ins (Fig.
3A, lane 2). JB
M treatment
converted the 3-1 glycan to GlcNAc-Ins, whereas A. satoi
1,2-mannosidase converted it to Man2-GlcNAc-Ins (Fig.
3B, lanes 2-5). These results indicate that the glycan of
lipid 3-1 contains three
-linked mannoses, the outermost of which is
in
-1,2 linkage. smp3 is therefore indeed defective in
the addition of the fourth,
-1,2-linked mannose to the GPI
precursor.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 3.
Characterization of the glycan headgroup of
lipid 3-1. Strain smp3-1 was radiolabeled with
[3H]inositol at 25 °C, and
[3H]inositol-labeled lipid 3-1 was isolated by
preparative TLC and deacylated with mild base. A, size
analysis of the neutral glycan. The headgroup was
re-N-acetylated with acetic anhydride and then
dephosphorylated with 50% aqueous HF, and the glycan was submitted to
HPTLC (lane 2). Lanes 3 and 4 contain
Man4-GlcNAc-[3H]Ins (M4) and
Man3-GlcNAc-[3H]Ins (M3) size
standards prepared from the Man4 GPIs that accumulate in
the gpi7 mutant (22). Lane 1 displays a series of NaB[3H]4-reduced
Glc2 (G2)-Glc6 (G6)
oligomers. B, -mannosidase sensitivity and positioning
EthN-P side branches. HF-dephosphorylated glycans were incubated JB M
(HF/JB M) (lane 3) or with A. satoi 1,2-mannosidase (HF/ 1,2M)
(lane 5). Mock-incubated controls for the digestions are
shown in lanes 2 and 4. A sample of deacylated,
re-N-acetylated headgroup was treated first with JB M and
then with HF (JB M/HF) (lane 6).
Glycans were separated by HPTLC and detected by fluorography. M0,
Ins, M1, M2, M3, and M4 indicate the positions of
GlcNAc-Ins, inositol, Man-GlcNAc-Ins, Man2-GlcNAc-Ins,
Man3-GlcNAc-Ins, and Man4-GlcNAc-Ins,
respectively. The mobilities of the GPI glycans relative to the
[3H]Glc oligomers correspond to those previously
published (27).
|
|
The finding that lipid 3-1 could be radiolabeled with
[3H]ethanolamine indicated the presence of one or more
EthN-Ps on this Man3-GPI. To determine the position of its
EthN-P side-branch(es), the deacylated 3-1 headgroup was first treated
with JB
M and then dephosphorylated and re-N-acetylated.
This succession of treatments yielded two major glycans, one migrating
as Man2-GlcNAc-Ins, the other as Man-GlcNAc-Ins (Fig.
3B, lane 6), indicating that lipid 3-1 is a mixture of
structural isoforms. The recovery of Man-GlcNAc-Ins indicates that the
GPI it originated from must have borne an EthN-P moiety on its first
mannose and therefore that only one EthN-P was present on the original
GPI. Because the GPI that gave rise to Man2-GlcNAc-Ins
comigrated with the one that yielded Man-GlcNAc-Ins, this
component of lipid 3-1 must likewise bear only one EthN-P side-branch.
We conclude that lipid 3-1 consists predominantly of a mixture of two
Man3-GPI isoforms, one bearing EthN-P on Man-2 and one
bearing EthN-P on its first Man. Because traces of material with the
mobility of Man3-GlcNAc-Ins were also present in the sample
in Fig. 3B, lane 6, it is possible that the lipid 3-1 mixture also contained a small amount of a Man3-GPI with a
single EthN-P moiety on Man-3, although the presence of this material
could also be explained by incomplete JB
M digestion.
smp3 Strains Have a Partial Defect in GPI Anchoring of
Protein--
We tested whether the smp3 mutants are
defective in GPI attachment to protein by examining GPI
anchor-dependent processing of Gas1p, a standard procedure
for detecting a GPI anchoring defect in yeast (49). A block in GPI
attachment to Gas1p in turn prevents maturation of a 125-kDa form of
the protein in the Golgi and causes Gas1p to remain in a
core-glycosylated, 105-kDa form (49). The two forms of Gas1p are
detected by pulse labeling smp3 cells with [35S]methionine at 25 or 37 °C and then performing a
chase during which cultures are maintained at 25 or 37 °C, after
which 35S-labeled Gas1p is immunoprecipitated. In the wild
type control strain, only the 125-kDa form of Gas1p was seen after the
chase period (Fig. 4, lanes 1 and 2), whereas in the
gpi1
control, only the 105-kDa protein was present after a 60-min chase at
37 °C (Fig. 4, lane 3). The smp3-2 mutant
showed a partial defect in Gas1p processing at 25 °C (Fig. 4,
lanes 4-6), as did the
gpi1 mutant
at 25 °C (38). Gas1p maturation remained incomplete at 37 °C in
smp3-2 (Fig. 4, lanes 7-9). The partial block in
Gas1p processing suggests that Smp3p is required for efficient transfer of GPIs to protein.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4.
smp3 is partially defective in
Gas1p processing. smp3-2 and wild type cells were
pulse-labeled at 25 or 37 °C, and gpi1
cells were labeled at 37 °C with Tran[35S]-label
mixture. Samples of the smp3 cultures were taken at the end
of the pulse labeling period (time 0, lanes 4 and
7). The radioactivity in the labeled cultures was then
chased with unlabeled amino acids for 30 or 60 min at 25 °C
(lanes 5 and 6) or 37 °C (lanes 8 and 9). 35S-Labeled Gas1p was then
immunoprecipitated from extracts of the cells, separated by
SDS-polyacrylamide gel electrophoresis, and detected by fluorography.
Lanes 1 and 2, [35S]Gas1p
immunoprecipitated from the wild type control strain after a 60-min
chase. Lane 3, [35S]Gas1p from
gpi1 cells after a 60-min chase.
|
|
Neither smp3-1, smp3-2, nor the
smp3-pGAL-SMP3 strain shifted to
glucose showed a discernible defect in [3H]inositol
incorporation into protein. The incompleteness of the Gas1p processing
block and the lack of effect on [3H]inositol
incorporation into protein may reflect a degree of leakiness of the
smp3 mutation or incomplete repression of SMP3 expression. Alternatively, a Man3-GPI may be transferred to
protein (see under "Discussion"), although if this is the case,
these aberrant protein-bound GPIs do not allow the cells to grow under nonpermissive conditions.
Smp3p-related Proteins Form a Subgroup of a Family of
Candidate Dol-P-Man-dependent
Mannosyltransferases--
Searches of sequence data bases revealed
that the genomes of S. pombe, C. albicans,
Drosophila melanogaster, and Homo sapiens encode
proteins resembling S. cerevisiae Smp3p. The
GenBankTM accession numbers of these protein
sequences are given under "Experimental Procedures." The new Smp3ps
show amino acid sequence similarity to the Alg9, Alg12, and
Pig-B(Gpi10) proteins but are unlikely to be the sequence and
functional homologs of these putative mannosyltransferases because the
S. pombe, D. melanogaster, and C. albicans
genomes all encode obvious counterparts of the latter proteins.
To show that the Smp3p-related proteins are indeed a separate subgroup
of the Alg9p/Alg12p/Pig-Bp(Gpi10p) family, we generated a CLUSTAL W
alignment of the amino acid sequences of 20 of these proteins and used
it to produce an unrooted phylogenetic tree using the DRAWTREE option
of the PHYLIP program (42). This analysis confirmed that the
Smp3p-related proteins represent a separate group, as do the proteins
designated the counterparts of Alg9p, Alg12p, and Pig-Bp(Gpi10p) (not
shown). The Smp3 proteins are also distinguishable from other members
of the family of putative mannosyltransferases because they have a
variation on an amino acid sequence motif (19) that characterizes these
proteins. Thus, the sequence 313HQEXRF in
the five Smp3-related proteins is HKEXRF in all Alg9, Alg12,
and Pig-B(Gpi10) proteins. (The first amino acid in these blocks is
numbered according to its position in S. cerevisiae Smp3p,
and X denotes a less conserved amino acid.) The family of
candidate mannosyltransferases seems to include only four easily recognizable relatives; our searches of eukaryotic protein sequences using various Smp3p, Alg9p, Alg12p, and Pig-Bp(Gpi10p) sequences as
probes have so far detected only proteins with obvious amino acid
sequence similarity to one or other of these four proteins.
We have not established whether the human Smp3p counterpart is the
functional equivalent of yeast Smp3p, but we note that the presence of
a human gene for such a protein is consistent with the fact that traces
of GPIs that have been speculated to bear a fourth Man have been
detected in lipid extracts of mammalian cells (13, 29).
Smp3p and Gpi10p Do Not Substitute for One Another in Vivo--
If
the Gpi10 and Smp3 proteins are mannosyltransferases, then they
transfer mannose to closely related GPI structures to form
-1,2-mannosidic linkages. We therefore tested whether these enzymes might exhibit any cross-specificity for each other's acceptor if
expressed at high levels in stains deficient in the other protein. However, overexpression of GPI10 behind its native promoter
on a 2µ plasmid neither restored the ability of
smp3-1 strains to grow at 37 °C nor had a discernible
effect on the lipid accumulation phenotype of smp3-1.
Further, smp3 null mutants could not be rescued by
overexpression of GPI10, and conversely, SMP3 did
not restore viability to gpi10 disruptants when present on a
2µ vector. Smp3p and Gpi10p therefore cannot substitute for
one another in vivo under the conditions used, indicating
that these putative mannosyltransferases have a high degree of
specificity for their respective acceptor GPIs in vivo.
 |
DISCUSSION |
The key findings reported here are that the essential Smp3 protein
is required for addition of the fourth Man to yeast GPI precursors;
that in the absence of Smp3p function, transfer of EthN-P to the third
GPI Man is severely, if not completely blocked; and that Smp3p function
is needed for efficient transfer of GPI precursors to yeast protein.
Function and Essential Role of Smp3p--
The simplest explanation
for the GPI assembly defect in smp3 mutants and for the fact
that Smp3p resembles other proteins implicated in the transfer of Man
from Dol-P-Man to manno-oligosaccharides is that Smp3p is the
mannosyltransferase that adds the fourth,
-1,2-linked Man during
assembly of yeast GPIs. Assuming that the primary biochemical defect in
conditional or null smp3 mutants is in the addition of the
fourth Man to GPIs, then this mannosyl residue itself must be critical,
either for completion of the substrate(s) of the transamidase complex
that adds GPIs to protein, or, if not for formation of
transfer-competent GPIs per se, then for some subsequent
function of the protein-bound GPI. We discuss these possibilities below.
The evidence to date strongly indicates that the GPI(s) that are
normally transferred to protein in yeast all bear a fourth,
-1,2-linked mannose residue. Thus, protein-bound GPIs in yeast bear
at least four mannoses (50), and the gaa1 and
gpi8 mutants, which are defective in GPI transfer to
protein, accumulate Man4-GPIs, the most prominent of which
is the complete precursor
Man-(EthN-P)Man-(EthN-P)Man-(EthN-P)Man-GlcN-(acyl-Ins)PI (27, 28).
Because smp3 is epistatic to gaa1, as well as to gpi11 and gpi13, which both accumulate
Man4-GPIs, Smp3p may be required for the formation of all
GPI transamidase substrates, or at least enough
"Man4-complete precursors" to maintain viability. The
latter possibility explains the fact that the Smp3p-deficient strains
we have tested show a partial defect in GPI transfer to protein.
Despite the strong lipid accumulation phenotype in these strains, they
might nonetheless be leaky and still capable of making Man4
transamidase substrates and attaching them to protein, although at
levels too low to support cell growth under nonpermissive conditions.
Another possibility, namely that the apparent leakiness of the
smp3 deficient strains is due to the transfer of
Man3GPIs to protein, is considered below.
If the presence of the fourth Man is indeed obligatory for a GPI to
serve as a transamidase substrate, then our results suggest a specific
requirement for this residue, namely, that the fourth mannose is
important or necessary for transfer of the "bridging EthN-P" to
Man-3 of the GPI precursor. Thus, Gpi13p-deficient mutants, which are
blocked in the addition of EthN-P to Man-3, accumulate a GPI with the
structure Man-Man-Man-(EthN-P)Man-GlcN-(acyl-Ins)PI (lipid 13-1 in Ref.
22; Fig. 2B, lane 1), suggesting that the acceptor GPI
recognized by Gpi13p is this Man4GPI. Our finding that the
smp3-2 mutation abolishes the formation of any detectable lipid 13-1 in the
smp3-2/
gpi13-pGAL-GPI13
strain (Fig. 2B, lane 6) in turn raises the possibility that
Gpi13p requires its acceptor GPI to bear a fourth mannose.
We note that if Gpi13p could act on a Man3-GPI before Smp3p
does, then a single smp3 mutant might be expected to show an
accumulation of trimannosyl GPIs bearing two or more EthN-Ps, which was
not observed.
Although the earliest consequence of an Smp3p deficiency is a
severe impairment in the formation of Man4-GPIs, including
the presumed acceptor for addition of the bridging EthN-P, it is
possible that the fourth Man plays its critical role after
GPI transfer to protein. Thus, EthN-P may be added to Man-3 of
Man3-GPIs in smp3 mutants, and such
Man3-GPIs may, in turn, be transferred to protein. This
would also explain the apparent leakiness of smp3 mutants
with respect to GPI transfer to protein. Lipid 3-1 contains traces of
material that could have originated from
(EthN-P)Man-Man-Man-GlcN-(acyl-Ins)PI (Fig. 3B, lane 6), a
species that could itself serve as GPI transamidase substrate and that
would accumulate in the smp3/gaa1 double mutant. However, if
(EthN-P)Man-Man-Man-GlcN-(acyl-Ins)PI were to receive additional EthN-P
side-branches on Man-1 or Man-2 or both and be converted to the
Man3 counterpart of complete precursors, then such species
should have been detectable in significant amounts in some of our lipid
radiolabeling experiments as polar GPIs with chromatographic mobilities
distinct from those of the known yeast Man4-GPIs. Traces of
polar lipids that are potential aberrant GPIs were detectable in
extracts of certain smp3 strains (Fig. 2B, lanes
5 and 6, asterisk) or became visible after prolonged exposure of TLC plates to x-ray film, but the amounts of these species
are too small to verify whether they are Man3-GPIs.
Importantly, however, if such trace lipids are indeed
Man3-GPIs capable of being transferred to protein, they
would be predicted to be present at much higher levels in the
smp3/gaa1 double mutant; however, no new polar lipids
accumulated when this transamidase-defective strain was shifted to
nonpermissive temperature (Fig. 2A, lane 10). We note too
that the smp3/gaa1 double mutant has a more severe growth
defect than either smp3 or gaa1 alone, suggesting
that Smp3p-dependent addition of the fourth Man is
necessary for the generation of optimal GPI transamidase substrates.
Although our results provide little support for the notion that
Man3-GPIs bearing two or more EthN-Ps are formed, they do not exclude the possibility that (EthN-P)Man-Man-Man-GlcN-(acyl-Ins)PI can be transferred to protein in smp3 mutants. However, even
if this occurred and some or all of the GPI anchors on yeast protein were to contain only three mannoses, this would not be sufficient for
growth, as indicated by the inviability of smp3 disruptants and the conditional lethality of the smp3-1 and
smp3-2 strains. The inability of protein-bound
Man3-GPIs to support growth in turn would imply that the
fourth mannose, which is normally present on all yeast GPI anchors
(50), fulfills another, essential function after anchor transfer to
protein. One possibility is that this additional Man is necessary for
incorporation of certain mannoproteins into the yeast cell wall upon
creation of a cross-link between a Man in the GPI and
-1,6-glucan
(4, 5). The fourth Man, however, may not form the attachment point for
all mannoproteins, because in some cell wall proteins, the linkage to
-glucan may be through the reducing end of a core GPI Man (5).
Another possible role for the fourth mannose on protein-bound GPIs,
consistent with the partial Gas1p processing defect of
smp3-2, is that the fourth mannose may be required for
efficient transport of GPI anchored proteins from the endoplasmic reticulum.
Although we cannot yet pinpoint the essential role of Smp3p, the
simplest reason why this protein is necessary is the one implied by the
earliest discernible biochemical consequence of a block in the addition
of the fourth Man to yeast GPI precursors, namely, an inability to form
Man-Man-Man-(EthN-P)Man-GlcN-(acyl-Ins)PI, the presumed acceptor for
EthN-P transfer to Man-3. This in turn implies that addition of the
fourth Man is critical for addition of the bridging EthN-P to Man-3 in
yeast. The incomplete block in GPI transfer to protein in
smp3 mutants must then be attributed to the leakiness of
these strains and their consequent ability to make and transfer some
Man4-complete precursor to protein, even though these
mutants accumulate Man3-GPIs lacking the bridging EthN-P.
The gpi10-1 strain provides a precedent for this
possibility; it has a strong lipid accumulation phenotype yet exhibits
neither an apparent GPI anchoring defect nor temperature sensitivity
for growth (19). Nonetheless, Gpi10p is an essential protein because it
is required for addition of the third mannose during GPI precursor assembly (19, 20).
Implications of the Structural Heterogeneity of Lipid 3-1 for
GPI Assembly in Yeast--
The major GPIs that can be radiolabeled in
yeast mutants can be arranged in a scheme that implies a branched
assembly pathway (22), and each of the two major isoforms of lipid 3-1 can be placed in one of the branches (Fig.
5). The
Man-Man-(EthN-P)Man-GlcN-(acyl-Ins)PI isoform of lipid 3-1 (lipid
3-1-1) can be inserted between the Gpi10p and Gpi13p steps in an
(EthN-P)Man-1 arm that is defined by a succession of intermediates from
Man-(EthN-P)Man-GlcN-(acyl-Ins)PI (19, 20) to complete precursor that
all bear EthN-P on Man-1 (19-23). The
Man-(EthN-P)Man-Man-GlcN-(acyl-Ins)PI isoform of 3-1 (lipid 3-1-2) is a
potential precursor of the Man4-GPI with EthN-P on Man-2
that accumulates in the gpi11 mutant (22). A
straightforward explanation for the formation of the latter two
GPIs is that they are intermediates in an (EthN-P)Man-2 arm of a
branched pathway. However, no obvious precursor to lipid 3-1-2 has been
identified in strains deficient in addition of the third GPI mannose.
Thus, although the gpi10 mutant accumulates
Man-(EthN-P)Man-GlcN-(acyl-Ins)PI, the likely precursor of lipid 3-1-1 (19, 20), strains with a Gpi10p-deficiency alone have not been reported
to accumulate Man-Man-GlcN-(acyl-Ins)PI or
(EthN-P)Man-Man-GlcN-(acyl-Ins)PI species that could serve as
precursors of lipid 3-1-2. Although an as yet undiscovered
Man-2-substituted GPI may be generated earlier, it is also possible
that pathway branching occurs after Gpi10p-dependent
addition of Man-3. This could involve an "isomerization" in which
EthN-P is removed from Man-1 and one is added to Man-2, or it could
involve the addition of EthN-P to Man-2 of an unsubstituted Man3-GPI. Although the latter GPI has not been demonstrated
unambiguously, it is possible that lipid 3-2 is indeed
Man-Man-Man-GlcN-(acyl-Ins)PI (Fig. 5), but we have so far been
unable to resolve sufficient amounts of lipid 3-2 for characterization
of its glycan headgroup.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Model for assembly pathway for yeast GPI
assembly and site of the smp3 block. Illustrated
are eight GPI structures that have been determined in detail (19-23)
and the steps that are blocked in GPI anchoring mutants.
Dashed arrows indicate the routes of the two putative
pathway branches; it is not known whether both pathways lead to
protein-bound GPIs or whether some GPIs remain "free." The
precursor of lipid 3-1-2 is unknown, but possible intermediates in its
synthesis are italicized, and the possibility that lipids
3-1-1 and 3-1-2 can be interconverted is indicated by a
double-headed arrow. The structures of the GPI(s) that
accumulate in mcd4 have not been determined, but
mcd4 is likely to be defective in EthN-P addition to Man-1
(18, 20, 56). M, mannose; G, glucosamine;
P, phosphate; E, ethanolamine.
|
|
We cannot rule out the formal possibility that the Man-2-substituted
GPIs of the (EthN-P)Man-2 pathway are nonphysiological lipids generated
only in GPI assembly mutants. However, the formation of
Man3- and Man4-GPIs lacking EthN-P on Man-1
suggests that addition of EthN-P to Man-1 is not absolutely required
for transfer of the third,
1,2-linked mannose, although treatment of
cells with an apparent inhibitor of EthN-P addition to Man-1 leads to
accumulation of Man-Man-GlcN-(acyl-Ins)PI (20).
Smp3p and Bridging EthN-P Addition as a Targets for Antimicrobial
Agents--
Because GPI synthesis is essential in fungi and protozoa
(6-9), this process could be targeted by drugs that exploit
differences between mammals and microbes in the enzymology of GPI
assembly. One proposed target is the addition of the first Man in
trypanosomal GPI biosynthesis, which, unlike in mammals, does not
require prior inositol acylation of GlcN-PI (51, 52). The
identification of a species-specific inhibitor of EthN-P transfer to
Man-1 (20, 53) indicates that even the same step in GPI assembly can be inhibited selectively in different organisms, a finding that validates the search for further selective inhibitors.
Our results suggest that both Smp3p-dependent
addition of the fourth mannose to GPI precursors and
Gpi13p-dependent transfer of the bridging EthN-P to a
Man4-GPI are reactions that could be targeted selectively
by antifungal agents. Thus, from the structures and relative abundance
of the GPI precursors that can be detected in mammalian cells, it is
clear that Man4-GPI precursors are at best rarely formed
and that the bridging EthN-P is readily added to Man-3 of a
Man3-GPI (13-18, 29). Moreover, cell lines deficient in
the mammalian counterparts of the GPI transamidase components Gpi8p and
Gaa1p accumulate Man3-GPIs with one to three EthN-P substituents, suggesting that the major mammalian GPI transamidase substrate has three mannoses (54, 55). This is consistent with the fact
that many protein-bound GPIs in mammalian cells have only three
mannoses (1, 51). The opposite holds in S. cerevisiae; all
protein-bound GPIs bear a fourth,
-1,2-linked mannose (50), the
presumed GPI transamidase subunits are Man4-GPIs, and the
results of the present study indicate that at best, only very small
amounts of Man3-GPIs bearing the bridging EthN-P can be
formed. The apparent rarity of free Man4-GPIs in mammalian cells raises the possibility that addition of a fourth mannose to GPI
precursors may be dispensable, in contrast to yeast, whereas Smp3p-dependent addition of Man-4 is essential for
viability. Smp3p therefore represents a potential target for antifungal
agents, and indeed, a likely Smp3p counterpart with 35% identity and
54% similarity to S. cerevisiae Smp3p is encoded in the
genome of the fungal pathogen C. albicans. We note that the
GPI biosynthetic intermediates made by P. falciparum also
include structures bearing a fourth mannose (25, 26); the transferase
that adds this mannose may therefore also be a potential target for
antimalarial agents.
The transferases that add the bridging EthN-P to fungal GPIs are also
potential drug targets. The Gpi13 and Pig-O proteins, which are
required for addition of EthN-P to Man-3 of yeast and mammalian GPI
precursors, respectively (22, 23, 29), appear to differ in their
specificities for GPI glycans. Thus, Pig-Op transfers EthN-P to a
Man3-GPI, whereas we have presented evidence here that its
sequence homolog, Gpi13p, shows strong, possibly absolute specificity
for a Man4-GPI as acceptor for the bridging EthN-P. This
difference in acceptor specificity could, in principle, also be
exploited in the development of antifungal drugs.
 |
ACKNOWLEDGEMENTS |
We thank Dr. L. Popolo for anti-Gas1p serum;
Drs. S. Harashima, D. Voelker, and M. Walberg for strains; and D. Meling for sequence analyses. Sequence data for C. albicans
were obtained from the Stanford DNA Sequencing and Technology Center
web site. Sequencing of C. albicans was accomplished
with the support of the National Institute of Dental and Craniofacial
Research and the Burroughs Wellcome Fund.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM46220 and by a Helen Corley Petit Professorship from the College of Liberal Arts and Sciences of the University of Illinois at
Urbana-Champaign.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a Burroughs Wellcome Fund Scholar Award in Pathogenic
Mycology. To whom correspondence should be addressed: Dept. of
Biochemistry, University of Illinois at Urbana-Champaign, 309 Roger
Adams Laboratory, 600 S. Mathews Ave., Urbana, IL 61801. Tel.:
217-333-4139; Fax: 217-244-5858; E-mail: p-orlean@uiuc.edu.
Published, JBC Papers in Press, May 16, 2001, DOI 10.1074/jbc.M101986200
2
B. A. Westfall and P. Orlean, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
GPI, glycosylphosphatidylinositol;
Dol-P-Man, dolichol phosphate mannose;
EthN-P, phosphoethanolamine;
HPTLC, high performance thin layer
chromatography;
JB
M, jack bean
-mannosidase;
Ins, inositol.
 |
REFERENCES |
| 1.
|
McConville, M. J.,
and Ferguson, M. A. J.
(1993)
Biochem. J.
294,
305-324
|
| 2.
|
Tiede, A.,
Bastisch, I.,
Schubert, J.,
Orlean, P.,
and Schmidt, R. E.
(1999)
Biol. Chem.
380,
503-523
|
| 3.
|
McConville, M. J.,
and Menon, A. K.
(2000)
Mol. Membr. Biol.
17,
1-16
|
| 4.
|
Lipke, P. N.,
and Ovalle, R.
(1998)
J. Bacteriol.
180,
3735-3740
|
| 5.
|
Fujii, T.,
Shimoi, H.,
and Iimura, Y.
(1999)
Biochim. Biophys. Acta
1427,
133-144
|
| 6.
|
Leidich, S. D.,
Drapp, D. A.,
and Orlean, P.
(1994)
J. Biol. Chem.
269,
10193-10196
|
| 7.
|
Colussi, P. A.,
and Orlean, P.
(1997)
Yeast
13,
139-150
|
| 8.
|
Ilgoutz, S. C.,
Zawadzki, J. L.,
Ralton, J. E.,
and McConville, M. J.
(1999)
EMBO J.
18,
2746-2755
|
| 9.
|
Nagamune, K.,
Nozaki, T.,
Maeda, Y.,
Ohishi, K.,
Fukuma, T.,
Hara, T.,
Schwarz, R. T.,
Brun, R.,
Riezman, H.,
and Kinoshita, T.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
10336-10341
|
| 10.
|
Kawagoe, K.,
Kitamura, D.,
Okabe, M.,
Taniuchi, I.,
Ikawa, M.,
Watanabe, T.,
Kinoshita, T.,
and Takeda, J.
(1996)
Blood
87,
3600-3606
|
| 11.
|
Stevens, V. L.
(1995)
Biochem. J.
310,
361-370
|
| 12.
|
Takeda, J.,
and Kinoshita, T.
(1995)
Trends Biochem. Sci.
20,
367-371
|
| 13.
|
Hirose, S.,
Prince, G. M.,
Sevlever, D.,
Ravi, L.,
Rosenberry, T. L.,
Ueda, E.,
and Medof, M. E.
(1992)
J. Biol. Chem.
267,
16968-16974
|
| 14.
|
Kamitani, T.,
Menon, A. K.,
Hallaq, Y.,
Warren, C. D.,
and Yeh, E. T. H.
(1992)
J. Biol. Chem.
267,
24611-24619
|
| 15.
|
Puoti, A.,
and Conzelmann, A.
(1992)
J. Biol. Chem.
267,
22673-22680
|
| 16.
|
Puoti, A.,
and Conzelmann, A.
(1993)
J. Biol. Chem.
268,
7215-7224
|
| 17.
|
Ueda, E.,
Sevlever, D.,
Prince, G. M.,
Rosenberry, T. L.,
Hirose, S.,
and Medof, M. E.
(1993)
J. Biol. Chem.
268,
9998-10002
|
| 18.
|
Hong, Y.,
Maeda, Y.,
Watanabe, R.,
Ohoshi, K.,
Mishkind, M.,
Riezman, H.,
and Kinoshita, T.
(1999)
J. Biol. Chem.
274,
35099-35106
|
| 19.
|
Canivenc-Gansel, E.,
Imhof, I.,
Reggiori, F.,
Burda, P.,
Conzelmann, A.,
and Benachour, A.
(1998)
Glycobiology
8,
761-770
|
| 20.
|
Sütterlin, C.,
Escribano, M. V.,
Gerold, P.,
Maeda, Y.,
Mazon, M. J.,
Kinoshita, T.,
Schwarz, R. T.,
and Riezman, H.
(1998)
Biochem. J.
332,
153-159
|
| 21.
|
Benachour, A.,
Sipos, G.,
Flury, I.,
Reggiori, F.,
Canivenc-Gansel, E.,
Vionnet, C.,
Conzelmann, A.,
and Benghezal, M.
(1999)
J. Biol. Chem.
274,
15251-15261
|
| 22.
|
Taron, C. H.,
Wiedman, J. M.,
Grimme, S. J.,
and Orlean, P.
(2000)
Mol. Biol. Cell
11,
1611-1630
|
| 23.
|
Flury, I.,
Benachour, A.,
and Conzelmann, A.
(2000)
J. Biol. Chem.
275,
24458-24465
|
| 24.
|
Sipos, G.,
Puoti, A.,
and Conzelmann, A.
(1994)
EMBO J.
13,
2789-2796
|
| 25.
|
Gerold, P.,
Dieckmann-Schuppert, A.,
and Schwarz, R. T.
(1994)
J. Biol. Chem.
269,
2597-2606
|
| 26.
|
Naik, R. S.,
Davidson, E. A.,
and Gowda, D. C.
(2000)
J. Biol. Chem.
275,
24506-24511
|
| 27.
|
Benghezal, M.,
Lipke, P. N.,
and Conzelmann, A.
(1995)
J. Cell Biol.
130,
1333-1344
|
| 28.
|
Hamburger, D.,
Egerton, M.,
and Riezman, H.
(1995)
J. Cell Biol.
129,
629-639
|
| 29.
|
Hong, Y.,
Maeda, Y.,
Watanabe, R.,
Inoue, N.,
Ohishi, K.,
and Kinoshita, T.
(2000)
J. Biol. Chem.
275,
20911-20919
|
| 30.
|
Homans, S.,
Ferguson, M.,
Dwek, R.,
Rademacher, T.,
Anand, R.,
and Williams, A.
(1988)
Nature
333,
269-272
|
| 31.
|
Brewis, I.,
Ferguson, M. A. J.,
Mehlert, A.,
Turner, A. J.,
and Hooper, N. M.
(1995)
J. Biol. Chem.
270,
22946-22956
|
| 32.
|
Sherman, F.
(1991)
Methods Enzymol.
194,
3-21
|
| 33.
|
Irie, K.,
Araki, H.,
and Oshima, Y.
(1991)
Mol. Gen. Genet.
225,
257-265
|
| 34.
|
Zieler, H. A.,
Walberg, M.,
and Berg, P.
(1995)
Mol. Cell. Biol.
15,
3227-3237
|
| 35.
|
Trotter, P. J.,
and Voelker, D. R.
(1995)
J. Biol. Chem.
270,
6062-6070
|
| 36.
|
Christianson, T. W.,
Sikorski, R. S.,
Dante, M.,
Shero, J.,
and Hieter, P.
(1992)
Gene
110,
119-122
|
| 37.
|
Schneider, P.,
and Ferguson, M. A. J.
(1995)
Methods Enzymol.
250,
614-630
|
| 38.
|
Leidich, S. D.,
and Orlean, P.
(1996)
J. Biol. Chem.
271,
27829-27837
|
| 39.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
|
| 40.
|
Altschul, S. F.,
Madden, T. L.,
Schäffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402
|
| 41.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680
|
| 42.
|
Felsenstein, J.
(1989)
Cladistics
5,
164-166
|
| 43.
|
Takahashi, M.,
Inoue, N.,
Ohishi, K.,
Maeda, Y.,
Nakamura, N.,
Endo, Y.,
Fujita, T.,
Takeda, J.,
and Kinoshita, T.
(1996)
EMBO J.
15,
4254-4261
|
| 44.
|
Orlean, P.
(1997)
in
The Molecular and Cellular Biology of the Yeast Saccharomyces. Cell Cycle and Cell Biology
(Pringle, J. R.
, Broach, J. R.
, and Jones, E. W., eds), Vol. 3
, pp. 229-362, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 45.
|
Burda, P.,
Jakob, C. A.,
Beinhauer, J.,
Hegemann, J. H.,
and Aebi, M.
(1999)
Glycobiology
9,
617-625
|
| 46.
|
Watanabe, R.,
Inoue, N.,
Westfall, B.,
Taron, C. H.,
Orlean, P.,
Takeda, J.,
and Kinoshita, T.
(1998)
EMBO J.
17,
877-885
|
| 47.
|
Gerring, S. L.,
Spencer, F.,
and Hieter, P.
(1990)
EMBO J.
13,
4347-4358
|
| 48.
|
Inoue, N.,
Kinoshita, T.,
Orii, T.,
and Takeda, J.
(1993)
J. Biol. Chem.
268,
6882-6885
|
| 49.
|
Nuoffer, C.,
Horvath, A.,
and Riezman, H.
(1993)
J. Biol. Chem.
268,
10558-10563
|
| 50.
|
Fankhauser, C.,
Homans, S. W.,
Thomas-Oates, J. E.,
McConville, M. J.,
Desponds, C.,
Conzelmann, A.,
and Ferguson, M. A. J.
(1993)
J. Biol. Chem.
268,
26365-26374
|
| 51.
|
Ferguson, M. A. J.,
Brimacombe, J. S.,
Brown, J. R.,
Crossman, A.,
Dix, A.,
Field, R. A.,
Güther, M. L. S.,
Milne, K. G.,
Sharman, D. K.,
and Smith, T. K.
(1999)
Biochim. Biophys. Acta
1455,
327-340
|
| 52.
|
Smith, T. K.,
Sharma, D. K.,
Crossman, A.,
Dix, A.,
Brimacombe, J. S.,
and Ferguson, M. A. J.
(1997)
EMBO J.
16,
6667-6675
|
| 53.
|
Sutterlin, C.,
Horvath, A.,
Gerold, P.,
Schwarz, R. T.,
Wang, Y.,
Dreyfuss, M.,
and Riezman, H.
(1997)
EMBO J.
16,
6374-6383
|
| 54.
|
Mohney, R. P.,
Knez, J. J.,
Ravi, L.,
Sevlever, D.,
Rosenberry, T. L.,
Hirose, S.,
and Medof, M. E.
(1994)
J. Biol. Chem.
269,
6536-6542
|
| 55.
|
Ohishi, K.,
Inoue, N.,
Maeda, Y.,
Takeda, J.,
Riezman, H.,
and Kinoshita, T.
(2000)
Mol. Biol. Cell
11,
1523-1533
|
| 56.
|
Gaynor, E. C.,
Mondésert, G.,
Grimme, S. J.,
Reed, S. I.,
Orlean, P.,
and Emr, S. D.
(1999)
Mol. Biol. Cell
10,
627-648
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
